Oncology

Latest News

Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

By Mary Caffrey

April 17th 2025

These advances are designed to improve uptake of biomarker-driven cancer care and reduce treatment delays.

Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

By Kyle Munz

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg

NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

By Giuliana Grossi

April 9th 2025

Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage

By Galen Shearn-Nance, BS
Rishi R. Sachdev, BS

April 4th 2025

Woman with keloid on shoulder | Image credit: weerajata – stock.adobe.com

Deep Learning Tool Differentiates Keloids From Malignant Lesions Without Dermoscopy

By Hayden E. Klein

April 2nd 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Watch Now

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

March 17th 2018

Podcast: This Week in Managed Care—Right-to-Try Bill Defeated and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

March 17th 2018

Patients With AML Have Significantly Lower Early Mortality at NCI-Designated Cancer Centers

Laura Joszt, MA

Patients with acute myeloid leukemia (AML) who were treated at a National Cancer Institute-designated cancer center had a 53% lower risk of early mortality, according to a study published in Cancer.

March 17th 2018

Ian Manners Explains the Impact of Patient Financial Assistance Programs

No one wants to think that they can’t afford the treatment, and they certainly don’t want to raise that issue with their physician, said Ian Manners, MBA, co-founder, CEO, Vivor.

March 17th 2018

CMS Finalizes Coverage for Next-Generation Sequencing Tests

Jaime Rosenberg

CMS has finalized a National Coverage Determination (NCD) that covers diagnostic laboratory tests that use Next Generation Sequencing (NGS) for patients with advanced cancer, according to a press release. The finalization comes a few months after the FDA granted approval to FoundationOne CDx, the first-of-a-kind comprehensive companion diagnostic test for solid tumors.

March 16th 2018

Technology Integration in Community Oncology Practice: Building the Future

Surabhi Dangi-Garimella, PhD

Finding inefficiencies in operational processes to identify gaps, improve symptom management and adherence, and optimizing value-based care—these are a few of the advantages of implementing technology in the daily operations of a community-based practice. This was the takeaway message from a series of presentations at the Association of Community Cancer Centers' 44th Annual Meeting & Cancer Center Business Summit, March 14-16, 2018, in Washington DC.

March 16th 2018

Barbara Tofani: The United States Underestimated the Need for Care Coordination

Care has become very complex and it isn’t enough to just give patients information and hope they can process it on their own, said Barbara Tofani, RN, MSN, NEA-BC, administrative director of the Hunterdon Regional Cancer Center.

March 16th 2018

False-Positive Mammography and Its Association With Health Service Use

Christine M. Gunn, PhD Barbara Bokhour, PhD Tracy A. Battaglia, MD, MPH Rebecca A. Silliman, MD, PhD Amresh Hanchate, PhD

This study demonstrated that a false-positive mammogram was associated with increases in outpatient visits, but not provider referrals, for 1 year post mammogram.

March 16th 2018

Investing in the Vital Role of a Cancer Care Coordinator

Surabhi Dangi-Garimella, PhD

At the Association of Community Cancer Centers' 44th Annual Meeting & Cancer Center Business Summit, held March 14-16, 2018, in Washington, DC, panelists shared strategies that have helped their organizations adapt to value-based care while ensuring that they never lose sight of the patient at the center of it all.

March 16th 2018

Michael Reff on Medically Integrated Dispensary in Value-Based Care

Michael Reff, executive director of National Community Oncology Dispensing Association (NCODA), discusses the role of the medically integrated dispensary in the transition to value-based payment models.

March 16th 2018

AJMC® in the Press, March 16, 2018

AJMC Staff

Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.

March 16th 2018

Why Tom Gallo Wants to Address Burnout During His Year as ACCC President

The increasing level of frustration that Tom Gallo saw in cancer care prompted him to choose burnout as the theme for his year as president of the Association of Community Cancer Centers (ACCC).

March 16th 2018

Development and Implementation of an Academic Cancer Therapy Stewardship Program

Amir S. Steinberg, MD Anish B. Parikh, MD Sara Kim, PharmD Damaris Peralta-Hernandez, RPh Talaat Aggour, BPharm Luis Isola, MD

A cancer therapy stewardship program can be used to improve clinical quality and patient care by emphasizing the importance of value and evidence in oncology.

March 16th 2018

Changing Trends in Oncology Practice: Value-Based Care and an Empowered Patient

Surabhi Dangi-Garimella, PhD

What are the biggest drivers of change in oncology care and what needs most attention? This was the crux of the discussion during an early panel at the Association of Community Cancer Centers' 44th Annual Meeting & Cancer Center Business Summit, held March 14-16, 2018, in Washington, DC.

March 16th 2018

Dr James Hamrick Outlines Challenges of Managing Clinical Trials and Benefits of Community Practices

The increasing complexity and personalization of clinical trials are major challenges for managing clinical trials, said James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health.

March 15th 2018

The Price of Innovation When Improving Cancer Care Delivery

Surabhi Dangi-Garimella, PhD

At the Association of Community Cancer Center’s 44th Annual Meeting & Cancer Center Business Summit, March 14-16, 2018, in Washington, DC, payer and physician representatives shared the stage with the president of a cancer foundation that is striving to break the barriers that prevent easy healthcare information exchange and access to cancer care.

March 15th 2018

NCI Researchers Find Drug May Prevent Resistance in Toxin-Based Leukemia Treatment

Samantha DiGrande

A new study recently published in Proceedings of the National Academy of Sciences has identified a possible solution for improving the efficacy of moxetumomab pasudotox, or moxe, in patients with relapsed and chemotherapy-resistant acute lymphoblastic leukemia.

March 15th 2018

Improving Quality of Care in Oncology Through Healthcare Payment Reform

Lonnie Wen, RPh, PhD Christine Divers, PhD Melissa Lingohr-Smith, PhD Jay Lin, PhD, MBA Scott Ramsey, MD, PhD

Overview of alternative payment models and how leading national organizations are involved with linking quality improvement initiatives and payment reform.

March 15th 2018

Dr Ali McBride: Addressing Adherence Issues With Patient Education

Patient education is critical for improving adherence as many patients don’t always know what their medications are or even how they can be taken with other medications they area already on, said Ali McBride, PharmD, MS, BCPS, clinical coordinator for University of Arizona Cancer Center.

March 15th 2018

Steven D'Amato Outlines Strategies for Improving Adherence to Oral Oncolytics

Information technology and an integrated clinical team can help improve medication adherence for patients receiving oral oncolytics, said Steven D'Amato, RPh, BSPharm, executive director of New England Cancer Specialists.

March 14th 2018

Breast Cancer Screening Guidelines May Lead to Delayed Diagnosis in Nonwhite Women

Kelly Davio

March 13th 2018

Pembrolizumab Granted Priority Review for Treatment of Cervical Cancer

Jaime Rosenberg

The FDA has accepted a new supplemental Biologics License Application and granted Priority Review for Merck's pembrolizumab (Keytruda) for the treatment of advanced cervical cancer, marking the first filing acceptance for an anti–PD-1 therapy in cervical cancer.

March 13th 2018

Dr Linda Frisk Discusses the Role of the Pharmacist in Value-Based Care

Linda Frisk, PharmD, of Arizona Oncology, discusses the role of the pharmacist in new value-based payment models and her experience with the Oncology Care Model (OCM).

March 13th 2018

ICER Outlines Planned Review of Antiandrogen Therapies for nmCRPC

Jaime Rosenberg

The Institute for Clinical and Economic Review (ICER) is requesting public comment on 3 antiandrogen therapies for nonmetastatic castrate-resistant prostate cancer (nmCRPC): abiraterone, enzalutamide, and apalutamide.

March 12th 2018

Dr Thomas Graf on the Impact of New Therapies in Oncology

Thomas Graf, MD, chief medical officer and vice president, Horizon Blue Cross Blue Shield of New Jersey, discusses the impact of increases in drug prices on oncology stakeholders.

March 10th 2018

Podcast: This Week in Managed Care—Verma on Health Data and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

March 10th 2018

Dr Thomas LeBlanc: Patients With Blood Cancer and Palliative Care

Thomas LeBlanc, MD, Duke Cancer Institute, discusses the trends of hospice care services used among patients with blood cancer compared with patients with solid tumors.

March 10th 2018

Tapping Into the Health Benefits of Social Networks Among Cancer Survivors

Surabhi Dangi-Garimella, PhD

Scientists at St. Jude Children’s Research Hospital have developed a new tool to measure the impact of social networks on the coping skills of adolescent and young adult cancer survivors.

March 10th 2018

Patients With Breast Cancer or Lymphoma Have Increased Risk of Heart Failure

Kaitlynn Ely

Patients who had breast cancer or lymphoma who were treated more than 3 times are more likely to develop congestive heart failure than those who did not have cancer, according to research being presented at the American College of Cardiology’s 67th Annual Scientific Session.

March 9th 2018

This Week in Managed Care: March 9, 2018

This week, the top managed care stories included Cigna's deal to buy Express Scripts; Seema Verma, Alex Azar, and Scott Gottlieb, MD, made the rounds at health conferences; an analysis finds FDA's accelerated approval pathway has been a success with hematology and oncology drugs.

March 8th 2018

Dr Adam Brufsky Outlines Care Coordination in Oncology

Care coordination is vital to ensure improved patient outcomes as both CMS and private payers are paying increased attention to it, pointed out Adam Brufsky, MD, PhD, co-director of the Comprehensive Breast Cancer Center at University of Pittsburgh. How is your institution infusing care coordination in its workflow?

...

51 52 53 54 55 56 57 58 59

...

184 >

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions